Archer Investment Corporation’s Elevation Oncology ELEV Stock Holding History

Archer Investment Corporation’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,298	Closed	-$476	–	1192
2025 Q2	$476	Hold	1,298	–	–	﹤0.01%	1083
2025 Q1	$336	Buy	+1,298	New	+$741	﹤0.01%	1064

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Archer Investment Corporation's ELEV Position: Q3 2025 in Review

Archer Investment Corporation sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 1,298 shares — an estimated $476 sold.

Archer Investment Corporation first reported a position in ELEV in Q1 2025 and held it in 2 quarters. The position peaked at $476 in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Archer Investment Corporation reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Archer Investment Corporation sold 1,298 Elevation Oncology shares in Q3 2025, an estimated $476.
Archer Investment Corporation first reported a position in Elevation Oncology in Q1 2025 and held it in 2 quarters.
Archer Investment Corporation's Elevation Oncology position peaked at $476 in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Archer Investment Corporation's 13F filing for Q3 2025, filed 3 Nov 2025.